364 related articles for article (PubMed ID: 9664150)
1. Serum zinc levels are increased in melanoma patients.
Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
Melanoma Res; 1998 Jun; 8(3):273-7. PubMed ID: 9664150
[TBL] [Abstract][Full Text] [Related]
2. Serum ceruloplasmin in melanoma patients.
Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
Anticancer Res; 2001; 21(1B):629-32. PubMed ID: 11299817
[TBL] [Abstract][Full Text] [Related]
3. Serum sialic acid in malignant melanoma patients: an ROC curve analysis.
Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
Anticancer Res; 1999; 19(4C):3619-22. PubMed ID: 10629661
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.
Hofmann MA; Gussmann F; Fritsche A; Biesold S; Schicke B; Küchler I; Voit C; Trefzer U
Melanoma Res; 2009 Feb; 19(1):17-23. PubMed ID: 19104451
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
Wu HY
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of the copper/zinc ratio in digestive cancer: a case control study.
Poo JL; Romero RR; Robles JA; Montemayor AC; Isoard F; Estanes A; Uribe M
Arch Med Res; 1997; 28(2):259-63. PubMed ID: 9204619
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on the clinical use of protein S-100B and MIA (melanoma inhibitory activity) in melanoma patients.
Schmitz C; Brenner W; Henze E; Christophers E; Hauschild A
Anticancer Res; 2000; 20(6D):5059-63. PubMed ID: 11326668
[TBL] [Abstract][Full Text] [Related]
8. [Laboratory markers of melanoma progression].
Bánfalvi T; Edesné MB; Gergye M; Udvarhelyi N; Orosz Z; Gilde K; Kremmer T; Ottó S; Tímár J
Magy Onkol; 2003; 47(1):89-104. PubMed ID: 12704461
[TBL] [Abstract][Full Text] [Related]
9. [Serum S100B protein and stage of cutaneous melanoma: a prospective study].
Brouard M; Quillien V; Ollivier I; Lesimple T; Adamski H; Chevrant-Breton J
Ann Dermatol Venereol; 2000 Jan; 127(1):56-9. PubMed ID: 10717564
[TBL] [Abstract][Full Text] [Related]
10. [Utility of the copper/zinc ratio in patients with lymphoma or acute or chronic leukemias].
Rosas R; Poo JL; Montemayor A; Isoard F; Majluf A; Labardini J
Rev Invest Clin; 1995; 47(6):447-52. PubMed ID: 8850142
[TBL] [Abstract][Full Text] [Related]
11. The value of serum zinc, copper, ceruloplasmin levels in patients with gastrointestinal tract cancers.
Boz A; Evliyaoğlu O; Yildirim M; Erkan N; Karaca B
Turk J Gastroenterol; 2005 Jun; 16(2):81-4. PubMed ID: 16252197
[TBL] [Abstract][Full Text] [Related]
12. Are serum zinc and copper levels useful as acute rejection markers in heart transplantation?
Domínguez JP; Cháfer M; Alonso A; Rodríguez MJ; Pulpón LA
J Heart Transplant; 1989; 8(3):264-7. PubMed ID: 2661778
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma.
Deichmann M; Benner A; Waldmann V; Bock M; Jäckel A; Näher H
J Exp Clin Cancer Res; 2000 Sep; 19(3):301-7. PubMed ID: 11144523
[TBL] [Abstract][Full Text] [Related]
14. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
[TBL] [Abstract][Full Text] [Related]
15. Serum copper and zinc concentrations in patients with chronic hepatitis B.
Cesur S; Cebeci SA; Kavas GO; Aksaray S; Tezeren D
J Infect; 2005 Jul; 51(1):38-40. PubMed ID: 15979489
[TBL] [Abstract][Full Text] [Related]
16. Copper and zinc concentrations in serum of healthy Greek adults.
Kouremenou-Dona E; Dona A; Papoutsis J; Spiliopoulou C
Sci Total Environ; 2006 Apr; 359(1-3):76-81. PubMed ID: 15955548
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study.
Poo JL; Rosas-Romero R; Montemayor AC; Isoard F; Uribe M
J Gastroenterol; 2003; 38(1):45-51. PubMed ID: 12560921
[TBL] [Abstract][Full Text] [Related]
18. Results of the determination of serum markers in patients with malignant melanoma.
Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
[TBL] [Abstract][Full Text] [Related]
19. Serum copper and zinc concentrations in patients with chronic hepatitis C.
Cesur S; Cebeci SA; Kavas GO; Yilmaz N; Buyukkagnici DI
J Infect; 2005 Jul; 51(1):35-7. PubMed ID: 15979488
[TBL] [Abstract][Full Text] [Related]
20. Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients.
Ugurel S; Rappl G; Tilgen W; Reinhold U
Clin Cancer Res; 2001 May; 7(5):1282-6. PubMed ID: 11350895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
